Category: Breaking

AstraZeneca Seeks Emergency Use Authorization In U.S. For Covid Prophylaxis Drug

Late-stage trials of the drug show it is 77% effective in reducing the risk of Covid-19 symptoms if administered as a preventive treatment.

New York’s Largest Healthcare Provider Fires 1,400 Employees Who Refused To Get Vaccinated

Northwell terminated more than 20 managers last week for refusing to get immunized against Covid-19.

Covid-19 Vaccine Mandates Are Working. Here’s The Proof.

Employer-issued mandates have accomplished their objective of quickly increasing inoculation rates among workers.

2021 Nobel Prize In Medicine Awarded To Scientists Who Discovered Temperature And Touch Receptors

The 2021 Nobel Prize in Medicine was awarded to American researchers David Julius and Ardem Patapoutian.

U.S. Covid Death Toll Passes 700,000 As Delta Surges In Some States

September was one of the United States’ deadliest months of the pandemic.

When Will We Have A Pill To Treat Covid? Here Are Three Antiviral Drugs Being Tested

Three pills to treat Covid-19 are undergoing late-stage clinical trials, the results of which could be out by the end of the year.

Louisiana Hospital Chain Hikes Insurance Premiums For Employees With Unvaccinated Spouses

Ochsner Health, Louisiana’s largest healthcare provider, will raise health insurance premiums for employees whose spouses or domestic partners covered under its benefits plan are not vaccinated against Covid-19, a decision CEO Warner Thomas said was in…

Moderna Crash Wipes Out $22 Billion In Value After Merck’s Covid Pill Triggers Vaccine Stock Plunge

Moderna tanked 15% Friday, while Novavax and BioNtech sank as much as 18%.

Israel’s Covid Booster Rollout Shows Early Success As Cases, Hospitalizations Plummet

The country had been battling a concerning surge of the virus in recent months.

Merck Says Its Antiviral Pill Cuts Risk Of Covid Hospitalizations, Deaths By Half

Merck said it would seek emergency approval for the first antiviral pill to treat Covid-19 off the back of the study.